Bioscience Archives

UA researchers land $2.27M grant to study Valley fever

Why are some people barely affected by Valley fever while others are admitted to intensive care? The search for answers to those questions is on, thanks to a $2.27 million grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to the University of Arizona Valley Fever… Read More →

Banner MD Anderson offers drug for neuroendocrine cancer

A new option for patients with a rare gastrointestinal tumor now is available at Banner MD Anderson Cancer Center in Gilbert as part of an expanded access clinical trial. The investigational drug is available to eligible patients with inoperable neuroendocrine carcinoma of midgut origin (carcinoid of the digestive tract), offering an alternative for patients who… Read More →

TGen concussion study may lead to better diagnosis, treatment

TGen concussion study of ASU football players
by in Bioscience | Healthcare

A three-year study of the Arizona State University football team will help researchers develop tools to better diagnose and prevent sports-related concussions and other injuries or diseases. The study, conducted by the Translational Genomics Research Institute, drew data from sensors placed inside players’ helmets during practices and games from 2013 to 2016. It combined the… Read More →

Flinn Foundation program picks 7 bioscience startups

Seven Arizona bioscience startup firms were competitively selected to participate in the 2017 Flinn Foundation Bioscience Entrepreneurship Program, which was established to foster entrepreneurship and help early-stage bioscience companies develop into successful and sustainable businesses in Arizona. The firms—based in Flagstaff, Phoenix, Scottsdale, Tempe and Tucson—will receive $30,000 each in funding support and program services… Read More →

BestCompaniesAZ names 100 Best Companies in Arizona

It is the purpose of BestCompaniesAZ and our calling – and has been for 15 years. We knew that better workplaces would create better lives, better communities, and more profitable businesses. Although it wasn’t about the money, the financial success was proven to be a benefit for best companies. Ten years ago, we were excited… Read More →

Colleen’s Dream helps TGen cancer research

Colleen’s Dream Foundation, a Scottsdale-based nonprofit, today announced a $30,000 grant to the Translational Genomics Research Institute (TGen) to research new ways of treating ovarian cancer. The grant will help fund research that builds on TGen’s discovery that mutations in a gene known as SMARCA4 drive a specific type of extremely aggressive ovarian cancer —… Read More →

How banking a baby’s Umbilical cord blood can help those fighting leukemia, lymphoma

baby chord blood

Minutes after my granddaughter was born I watched as the nurse collected her cord blood for banking. It was so easy and it only took a few minutes. Today, cord blood stem cells donated from another Mom and Baby will be used to help save the life of someone I love who is fighting acute… Read More →

TGen finds mutation linked to child’s development

Researchers at TGen (Translational Genomics Research Institute) have identified a genomic mutation that causes physical abnormalities and developmental delays in children. Upon analyzing the genome of a six-year-old boy, the scientists identified a novel mutation that affects a protein known as CASK, which is key to brain development and the signals transmitted by brain cells,… Read More →

Understanding Ducey’s $1 billion university research infrastructure plan

bioscience

Lasting economic impact, the kind that spans generations and creates jobs today and in the future, depends on a series of strategic investments and commitments made by both the public sector and the private sectors. AZBio applauds Governor Doug Ducey for his foresight and commitment to the future of Arizona as demonstrated by his plan… Read More →

CTCA recruits patients for groundbreaking clinical trial

VisionGate

Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) will be the first hospital in Arizona to work on a groundbreaking targeted drug trial for cancer treatment. The study launched earlier this year and will evaluate molecularly targeted cancer drugs and collect data on clinical outcomes to learn about additional uses of… Read More →

TGen and Banner Health announce concussion study

Banner Health and the Translational Genomics Research Institute (TGen) formed a partnership to find a quicker and more accurate way of diagnosing concussions.  Specifically, Banner and TGen will obtain bio-samples from as many as 100 volunteer patients in an effort to find a biomarker — a genetic signature — that can definitively indicate when a patient has suffered… Read More →

VisionGate presents trial data at lung cancer conference

Many physicians have to take a wait and see approach when a nodule is found inside of a patient’s lung. But VisionGate recently revealed a non-invasive LuCED test on sputum for the early detection of lung cancer may offer an alternative, non-invasive next step for patients. More than 1.5 million people in the United States will… Read More →

NCI funds TGen-led cancer study training

brain cancer

The National Cancer Institute (NCI) awarded a 5-year, $1.125 million grant to continue an innovative and unique oncology training program for newly minted physicians developed and overseen by Dr. Daniel Von Hoff, distinguished professor and physician-in-chief at the Translational Genomics Research Institute (TGen). Convened by the American Association for Cancer Research (AACR) and the American Society… Read More →

TGen study says treat brain tumors based on complexity

Survival for patients with glioblastoma, an aggressive and deadly brain cancer, could be determined by the complexity of their tumor, according to researchers at the Translational Genomics Research Institute (TGen). The findings from a recent study suggest — to the researchers’ surprise — that the survival of those patients whose cancer cells exhibit a complex genomic… Read More →